A NON-PROFIT ORGANIZATION TO SPREAD AWARENESS ABOUT HPV THROAT CANCER
- Education 20 million Americans are currently infected with HPV. Learn about HPV infection and who is at risk of getting HPV throat cancer.
- Prevention The CDC recommends the HPV vaccine for females age 11-26 and males age 11 to 21.
- Support Find about clinical trials for HPV throat cancer patients.
- Support Learn how to enjoy eating again after treatment and how to live your best new normal.
- Get Involved Share your story, read about others' experiences. Together, we can help and learn from each other.
The American Society of Clinical Oncologists says by 2020, the number of cases of HPV-related oropharyngeal cancers in middle-age, non-smoking men will surpass that of cervical cancer. Women can also get it.
The best prevention is vaccination AND early awareness of throat cancer symptoms: lump in the throat, difficulty swallowing, hoarseness or unusually persistent sore throat. See your doctor and if the symptoms persist, see a Head and Neck specialist without delay. Doctors say with early detection, the prognosis for HPV-related throat cancer in non-smoking patients is at least 90%.
Our gratitude to HPV throat cancer patients and caregivers who are willing to share their personal stories to help others.
See Personal Stories.
Share your story. Some people like to write about their stories but we’ve also made it easy to record your own story. Learn more.
If you’ve been diagnosed with HPV-positive head or neck cancer, you may be eligible. This clinical trial seeks to reduce the long-term side effects from radiation such as dry mouth, difficulty swallowing, and altered taste. Watch:
Dr. Sara Pai is a lead researcher of HPV oropharyngeal cancer at Harvard Medical School and practices otolaryngology at Massachusetts General Hospital. She is a former associate professor at Johns Hopkins School of Medicine, Department of Otolaryngology – Head and Neck Surgery. Watch our videos: Dr. Pai answers common questions about HPV infection, vaccination, and throat cancer, as well as current and upcoming clinical trials.
New research in the Journal of Cancer Policy outlines the need for an “oncopolicy” among high-income countries to find “actionable strategies that policy-makers could implement to reduce the number of people diagnosed with the disease, enhance the quality of life for those living with the disease and lessen the likelihood of dying from the disease.”
Read the op-ed by Dr. Anees B. Chagpar, associate professor at the Yale University School of Medicine, Department of Surgery with a particular interest in public health as it pertains to cancer. Dr. Chagpar says, “ … less than a third of people with a less than high school education are aware of a potentially cancer preventing vaccine, we know we can be doing better. “
NOTE: Unless attributed to a doctor or medical organization, all views on HPVANDME.ORG are published from personal experience only and not intended to be any form of medical advice. Always consult your doctor.